Literature DB >> 6187878

Isotypic and allotypic specificity of mouse rheumatoid factors.

J L Van Snick, V Stassin, B de Lestré.   

Abstract

The specificity of polyclonal mouse rheumatoid factors (RF) was analyzed by competition experiments with heat-aggregated mouse IgG subclasses. The RF spontaneously produced by three normal mouse strains (129/Sv, CBA/Ht, and C57Bl/6) and by two strains with autoimmune diseases (MRL/l and NZB) were found to consist of distinct non-cross-reactive antibody subpopulations each specific for one IgG subclass. The sera of the normal strains contained IgG1- and IgG2a-specific RF. The autoimmune strains produced an additional variety of RF that was specific for The autoimmune strains produced an additional variety of RF that was specific for IgG2b. Also, the RF secreted by spleen cells of various normal strains after in vitro polyclonal activation with lipopolysaccharide could be resolved into distinct subpopulations specific for IgG1 or IgG2a. These results were confirmed by the analysis of monoclonal RF derived from BALB/c, C57Bl/6, CBA/Ht, and 129/Sv mice: of 73 hybridomas with RF activity, 71 displayed a strict subclass specificity. The subclass predominantly recognized depended on the origin of the spleen cells used to generate the hybridomas. After polyclonal activation in vitro, a broad spectrum of different specificities was obtained with 16 RF specific for IgG1, 13 for IgG2a, and 4 for IgG2b. In contrast, 27 of 28 monoclonal RF derived from 129/Sv and BALB/c mice without prior polyclonal activation were specific for IgG2a, and of these 75% were allotype specific since they failed to react with IgG2a of the b allotype. These results demonstrate the importance of subclass specificity in the production of RF in vivo. With the exception of the IgG2b-specific clones, all these monoclonal RF reacted preferentially with heat-aggregated or antigen-bound IgG. Among the hybridomas generated by the fusion of in vitro polyclonally activated spleen cells of 4-wk-old mice, the frequency of clones with RF activity was at least 40 times higher than that of clones specific for mouse IgM, human IgG, ovalbumin, and hen lysozyme.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187878      PMCID: PMC2186951          DOI: 10.1084/jem.157.3.1006

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Most IgM-producing cells in the mouse secrete auto-antibodies (rheumatoid factor).

Authors:  D W Dresser
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

3.  Hidden rheumatoid factors with specificity for native gamma globulins.

Authors:  J C Allen; H G Kunkel
Journal:  Arthritis Rheum       Date:  1966-12

4.  Gm(g)--a "new" gamma-globulin factor.

Authors:  J B Natvig
Journal:  Nature       Date:  1966-07-16       Impact factor: 49.962

5.  Localization of Gm markers to different molecular regions of the Fc fragment.

Authors:  J B Natvig; M W Turner
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

6.  Induction of an IgM anti-(bovine)-IgG response in mice by bacterial lipopolysaccharide.

Authors:  D W Dresser; A M Popham
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

7.  IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides.

Authors:  S Izui; R A Eisenberg; F J Dixon
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

8.  Relative reactivities of rheumatoid factors in serum and cells. Evidence for a selective deficiency in serum rheumatoid factor.

Authors:  D L Robbins; T L Moore; D A Carson; J H Vaughan
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

9.  Age-dependent production of IgA and IgM autoantibodies against IgG2a in a colony of 129/Sv mice.

Authors:  J L van Snick; P L Masson
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

10.  Incidence and specificities of IgA and IgM anti-AgG autoantibodies in various mouse strains and colonies.

Authors:  J L van Snick; P L Masson
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  7 in total

1.  Agonistic antibodies to Fas induce a breach in the endothelial lining of the liver and a breakdown in B cell tolerance.

Authors:  M M Newkirk; U Nowak; E Skamene; D Iera; J Desbarats
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Rheumatoid factors in mice bearing the lpr or gld mutation. Selective production of rheumatoid factor cryoglobulins in MRL/MPJ-lpr/lpr mice.

Authors:  T Shibata; T Berney; F Spertini; S Izui
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

3.  Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.

Authors:  Karen M Haas; Rei Watanabe; Takashi Matsushita; Hiroko Nakashima; Nobuko Ishiura; Hitoshi Okochi; Manabu Fujimoto; Thomas F Tedder
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

4.  Binding of in vivo formed immune complexes by monoclonal mouse rheumatoid factors.

Authors:  J P Coutelier; J Van Snick
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

5.  Heterogeneity in rheumatoid factor isotypes and specificities in MRL mice.

Authors:  A Bond; A Cooke; F C Hay
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

6.  A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21)

Authors:  V E Jones; A H Puttick; E A Williamson; R A Mageed
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

7.  Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins.

Authors:  V Stassin; P G Coulie; B K Birshtein; D S Secher; J Van Snick
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.